Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome

Josi A. Camacho, Rebecca Mardach, Natalia Rioseco-Camacho, Eduardo Ruiz-Pesini, Olga Derbeneva, Dario Andrade, Frank Zaldivar, Yong Qu, Stephen D. Cederbaum

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We studied two related families (HHH013 and HHH015) with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, a disorder of the urea cycle and ornithine degradation pathway, who have the same novel ornithine transporter (ORNT1) genotype (T32R) but a variable phenotype. Both HHH015 patients are doing well in school and are clinically stable; conversely, the three affected HHH013 siblings had academic difficulties and one suffered recurrent episodes of hyperammonemia and ultimately died. Overexpression studies revealed that the product of the ORNT1-T32R allele has residual function. Ornithine transport studies in HHH015 fibroblasts, however, showed basal activity similar to fibroblasts carrying nonfunctional ORNT1 alleles. We also examined two potential modifying factors, the ORNT2 gene and the mitochondrial DNA lineage (haplogroup). Haplogroups, associated with specific diseases, are hypothesized to influence mitochondrial function. Results demonstrated that both HHH015 patients are heterozygous for an ORNT2 gain of function polymorphism and belong to haplogroup A whereas the HHH013 siblings carry the wild-type ORNT2 and are haplogroup H. These observations suggest that the ORNT1 genotype cannot predict the phenotype of HHH patients. The reason for the phenotypic variability is unknown, but factors such as redundant transporters and mitochondrial lineage may contribute to the neuropathophysiology of HHH patients.

Original languageEnglish (US)
Pages (from-to)423-429
Number of pages7
JournalPediatric Research
Volume60
Issue number4
DOIs
StatePublished - Oct 1 2006
Externally publishedYes

Fingerprint

Mutation
Ornithine
Siblings
Inborn Urea Cycle Disorder
Fibroblasts
Alleles
Genotype
Hyperammonemia
Phenotype
Mitochondrial DNA
HHH syndrome
Genes
ornithine transporter

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. / Camacho, Josi A.; Mardach, Rebecca; Rioseco-Camacho, Natalia; Ruiz-Pesini, Eduardo; Derbeneva, Olga; Andrade, Dario; Zaldivar, Frank; Qu, Yong; Cederbaum, Stephen D.

In: Pediatric Research, Vol. 60, No. 4, 01.10.2006, p. 423-429.

Research output: Contribution to journalArticle

Camacho, JA, Mardach, R, Rioseco-Camacho, N, Ruiz-Pesini, E, Derbeneva, O, Andrade, D, Zaldivar, F, Qu, Y & Cederbaum, SD 2006, 'Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome', Pediatric Research, vol. 60, no. 4, pp. 423-429. https://doi.org/10.1203/01.pdr.0000238301.25938.f5
Camacho, Josi A. ; Mardach, Rebecca ; Rioseco-Camacho, Natalia ; Ruiz-Pesini, Eduardo ; Derbeneva, Olga ; Andrade, Dario ; Zaldivar, Frank ; Qu, Yong ; Cederbaum, Stephen D. / Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. In: Pediatric Research. 2006 ; Vol. 60, No. 4. pp. 423-429.
@article{71402641c17042cdb0cba8ccc1c60888,
title = "Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome",
abstract = "We studied two related families (HHH013 and HHH015) with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, a disorder of the urea cycle and ornithine degradation pathway, who have the same novel ornithine transporter (ORNT1) genotype (T32R) but a variable phenotype. Both HHH015 patients are doing well in school and are clinically stable; conversely, the three affected HHH013 siblings had academic difficulties and one suffered recurrent episodes of hyperammonemia and ultimately died. Overexpression studies revealed that the product of the ORNT1-T32R allele has residual function. Ornithine transport studies in HHH015 fibroblasts, however, showed basal activity similar to fibroblasts carrying nonfunctional ORNT1 alleles. We also examined two potential modifying factors, the ORNT2 gene and the mitochondrial DNA lineage (haplogroup). Haplogroups, associated with specific diseases, are hypothesized to influence mitochondrial function. Results demonstrated that both HHH015 patients are heterozygous for an ORNT2 gain of function polymorphism and belong to haplogroup A whereas the HHH013 siblings carry the wild-type ORNT2 and are haplogroup H. These observations suggest that the ORNT1 genotype cannot predict the phenotype of HHH patients. The reason for the phenotypic variability is unknown, but factors such as redundant transporters and mitochondrial lineage may contribute to the neuropathophysiology of HHH patients.",
author = "Camacho, {Josi A.} and Rebecca Mardach and Natalia Rioseco-Camacho and Eduardo Ruiz-Pesini and Olga Derbeneva and Dario Andrade and Frank Zaldivar and Yong Qu and Cederbaum, {Stephen D.}",
year = "2006",
month = "10",
day = "1",
doi = "10.1203/01.pdr.0000238301.25938.f5",
language = "English (US)",
volume = "60",
pages = "423--429",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome

AU - Camacho, Josi A.

AU - Mardach, Rebecca

AU - Rioseco-Camacho, Natalia

AU - Ruiz-Pesini, Eduardo

AU - Derbeneva, Olga

AU - Andrade, Dario

AU - Zaldivar, Frank

AU - Qu, Yong

AU - Cederbaum, Stephen D.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - We studied two related families (HHH013 and HHH015) with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, a disorder of the urea cycle and ornithine degradation pathway, who have the same novel ornithine transporter (ORNT1) genotype (T32R) but a variable phenotype. Both HHH015 patients are doing well in school and are clinically stable; conversely, the three affected HHH013 siblings had academic difficulties and one suffered recurrent episodes of hyperammonemia and ultimately died. Overexpression studies revealed that the product of the ORNT1-T32R allele has residual function. Ornithine transport studies in HHH015 fibroblasts, however, showed basal activity similar to fibroblasts carrying nonfunctional ORNT1 alleles. We also examined two potential modifying factors, the ORNT2 gene and the mitochondrial DNA lineage (haplogroup). Haplogroups, associated with specific diseases, are hypothesized to influence mitochondrial function. Results demonstrated that both HHH015 patients are heterozygous for an ORNT2 gain of function polymorphism and belong to haplogroup A whereas the HHH013 siblings carry the wild-type ORNT2 and are haplogroup H. These observations suggest that the ORNT1 genotype cannot predict the phenotype of HHH patients. The reason for the phenotypic variability is unknown, but factors such as redundant transporters and mitochondrial lineage may contribute to the neuropathophysiology of HHH patients.

AB - We studied two related families (HHH013 and HHH015) with the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome, a disorder of the urea cycle and ornithine degradation pathway, who have the same novel ornithine transporter (ORNT1) genotype (T32R) but a variable phenotype. Both HHH015 patients are doing well in school and are clinically stable; conversely, the three affected HHH013 siblings had academic difficulties and one suffered recurrent episodes of hyperammonemia and ultimately died. Overexpression studies revealed that the product of the ORNT1-T32R allele has residual function. Ornithine transport studies in HHH015 fibroblasts, however, showed basal activity similar to fibroblasts carrying nonfunctional ORNT1 alleles. We also examined two potential modifying factors, the ORNT2 gene and the mitochondrial DNA lineage (haplogroup). Haplogroups, associated with specific diseases, are hypothesized to influence mitochondrial function. Results demonstrated that both HHH015 patients are heterozygous for an ORNT2 gain of function polymorphism and belong to haplogroup A whereas the HHH013 siblings carry the wild-type ORNT2 and are haplogroup H. These observations suggest that the ORNT1 genotype cannot predict the phenotype of HHH patients. The reason for the phenotypic variability is unknown, but factors such as redundant transporters and mitochondrial lineage may contribute to the neuropathophysiology of HHH patients.

UR - http://www.scopus.com/inward/record.url?scp=33748909137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748909137&partnerID=8YFLogxK

U2 - 10.1203/01.pdr.0000238301.25938.f5

DO - 10.1203/01.pdr.0000238301.25938.f5

M3 - Article

C2 - 16940241

AN - SCOPUS:33748909137

VL - 60

SP - 423

EP - 429

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 4

ER -